STXS

Stereotaxis Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 3/10
  • Value 0/10
Stereotaxis sales and earnings growth
STXS Growth
Neutral
  • Revenue Y/Y 20.28%
  • EPS Y/Y 16.67%
  • FCF Y/Y -61.51%
Stereotaxis gross and profit margin trends
STXS Profitability
Fair
  • Gross margin 52.70%
  • EPS margin -70.80%
  • ROIC 5Y -171.30%
Stereotaxis net debt vs free cash flow
STXS Risk
Great
  • Debt / Equity 0.3
  • Debt / FCF 0.0
  • Interest coverage 999.0

Stereotaxis stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗